Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Boc-amido-PEG9-amine | 890091-43-7 | ≥98.0% | C25H52N2O11 | 50 MG
SDP

Catalog No. 5000357218
Encompass_Preferred

Boc-amido-PEG9-amine is a PEG-based PROTAC linker utilized in the synthesis of PROTACs. PROTACs are designed with two distinct ligands connected by a linker, one binding to an E3 ubiquitin ligase and the other to a target protein. This mechanism exploits the intracellular ubiquitin-proteasome system to facilitate the selective degradation of target proteins.

  • Can be used in the synthesis of PROTACs
  • PROTACs contain two different ligands connected by a linker
  • Ligand for an E3 ubiquitin ligase
  • Ligand for the target protein
  • Exploits the intracellular ubiquitin-proteasome system
  • Selectively degrades target proteins

Catalog No. 50-003-57218 Supplier Medchemexpress LLC Supplier No. HY14023350MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Boc-amido-PEG9-amine is a PEG-based PROTAC linker utilized in the synthesis of PROTACs. PROTACs are designed with two distinct ligands connected by a linker, one binding to an E3 ubiquitin ligase and the other to a target protein. This mechanism exploits the intracellular ubiquitin-proteasome system to facilitate the selective degradation of target proteins.

  • Can be used in the synthesis of PROTACs
  • PROTACs contain two different ligands connected by a linker
  • Ligand for an E3 ubiquitin ligase
  • Ligand for the target protein
  • Exploits the intracellular ubiquitin-proteasome system
  • Selectively degrades target proteins

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.